To evaluate risk factors for cervical intraepithelial neoplasia (CIN), data were collected in a case-control study based on 366 patients (58 with CIN class 1, 70 with CIN class 2, and 238 with CIN class 3) and 323 control subjects with normal cervical smears interviewed on selected days at the same
Screening strategies for cervical cancer and cervical intraepithelial neoplasia
β Scribed by Ralph M. Richart; Bruce A. Barron
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 593 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
During 1977During -1983, 787 , 787 consecutive referred cases of CJN were treated by vaporization of a dome-shaped defect, by excision of a cylindrical specimen, or a combination of procedures where 48 % were CIN 111. Vaporization was used for 72% of CIN I, 76% of CIN 11, and 64% of CIN 111 cases.
## Abstract Infection with highβrisk human papillomavirus (HPV) causes cervical intraepithelial neoplasia (CIN) and invasive cervical cancer (ICC). The distribution of HPV types in cervical diseases has been previously described in small studies for Canadian women. The prevalence of 36 HPV genotype
## Abstract Invasive cancer of the cervix after treatment for cervical intraepithelial neoplasia (CIN) is becoming more important, as screening reduces the incidence of invasive disease. The rate of invasive cervical or vaginal cancer following treatment for CIN in UK remains elevated for at least